AEs leading to discontinuation of pomalidomide or both treatments, according to system organ class (n = 50)
AEs leading to discontinuation of pomalidomide or both treatments . | n (%) . |
---|---|
Blood and lymphatic system disorders | |
Anemia | 1 (2) |
Neutropenia | 1 (2) |
Febrile neutropenia | 1 (2) |
Thrombocytopenia | 1 (2) |
Musculoskeletal and connective tissue disorders | 2 (4) |
Bone pain | 2 (4) |
Pulmonary embolism | 1 (2) |
Infections | 4 (8) |
Septic shock | 3 (6) |
AEs leading to discontinuation of pomalidomide or both treatments . | n (%) . |
---|---|
Blood and lymphatic system disorders | |
Anemia | 1 (2) |
Neutropenia | 1 (2) |
Febrile neutropenia | 1 (2) |
Thrombocytopenia | 1 (2) |
Musculoskeletal and connective tissue disorders | 2 (4) |
Bone pain | 2 (4) |
Pulmonary embolism | 1 (2) |
Infections | 4 (8) |
Septic shock | 3 (6) |